Shares of Aytu BioPharma, Inc. (NASDAQ:AYTU – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.36 and traded as low as $1.07. Aytu BioPharma shares last traded at $1.07, with a volume of 24,552 shares changing hands.
Aytu BioPharma Stock Performance
The stock has a market cap of $6.60 million, a price-to-earnings ratio of -0.74 and a beta of 0.07. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.98 and a quick ratio of 0.81. The firm has a fifty day moving average of $1.36 and a 200 day moving average of $1.70.
Aytu BioPharma (NASDAQ:AYTU – Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported ($0.28) earnings per share (EPS) for the quarter. Aytu BioPharma had a negative net margin of 7.62% and a negative return on equity of 19.30%.
About Aytu BioPharma
Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.
Featured Stories
- Five stocks we like better than Aytu BioPharma
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Bank Stocks – Best Bank Stocks to Invest In
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- How to Short a Stock in 5 Easy Steps
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Aytu BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
